Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Shares Outstanding (Diluted Average) (2016 - 2025)

Sanara MedTech's Shares Outstanding (Diluted Average) history spans 10 years, with the latest figure at $8.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 1.64% year-over-year to $8.6 million; the TTM value through Dec 2025 reached $8.6 million, up 1.64%, while the annual FY2025 figure was $8.6 million, 1.64% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $8.6 million in Q4 2025 per SMTI's latest filing, down from $8.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $8.9 million in Q3 2025 to a low of $7.9 million in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $8.4 million, with a median of $8.4 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 0.78% in 2023, then increased 5.19% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $7.9 million in 2022, then rose by 4.71% to $8.3 million in 2023, then grew by 2.48% to $8.5 million in 2024, then rose by 1.64% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Shares Outstanding (Diluted Average) are $8.6 million (Q4 2025), $8.9 million (Q3 2025), and $8.6 million (Q2 2025).